Clinical trials: Heroin
Opioid Dependence
A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence
This study will measure the amount of buprenorphine found in the blood after taking sublingual buprenorphine tablets versus after implantation with 4 Probuphine (buprenorphine implants).
- Trial name
- PRO-810 (NCT00768482)
- Testing
- Probuphine (buprenorphine implant), Sublingual Buprenorphine
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- Titan Pharmaceuticals
Opioid-Related Disorders, Heroin Dependence
Ability of Aprepitant to Block Opioid Reward in Non-Dependent Opiate Abusers
The objective of this study is to determine whether aprepitant blocks the opiate reward system in non-dependent opiate abusers, indicating its potential as a safe, non-addictive first line therapy for early heroin abuse.
- Conditions
- Opioid-Related Disorders, Heroin Dependence, Substance-Related Disorders
- Trial name
- NCT00726960
- Testing
- aprepitant
- Where
- Sweden
- Volunteers
- 60 people
- Sponsor
- Karolinska University Hospital
Opiate Dependence
Remote Observed Dosing to Increase Suboxone Compliance
The goal of this project is to test the feasibility, acceptability, and preliminary efficacy of using remote compliance monitoring in buprenorphine (Suboxone®) treatment for opiate dependence.
- Trial name
- RODISC (NCT01779973)
- Testing
- Remote Observed Dosing
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- University of Pennsylvania
Opioid-Related Disorders, Heroin Dependence
Depot Naltrexone Mechanism of Action in Heroin Dependent Patients Using fMRI and SPECT
The aim of this project is to study brain functions of 20 heroin addicts (compared to brain functions of 20 healthy controls) just before and during a three month extended release naltrexone treatment using functional MRI and…
- Trial name
- XRNT (NCT01471145)
- Testing
- Naltrexone
- Where
- Netherlands
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Non-communicable Diseases (NCD), Addiction to Opioids
Systematic Examination of Health Inequalities: Documentation, Patterns, and Determinants
The existence of social inequalities is a major global issue and a salient challenge for the European Union. During COVID-19 pandemic, health disparities became more evident.
- Conditions
- Non-communicable Diseases (NCD), Addiction to Opioids, Incarceration, Opioid-use Disorders
- Trial name
- CHANCE (NCT07558187)
- Where
- 5 sites in Greece
- Volunteers
- 2,000 people, healthy volunteers welcome
- Sponsor
- University of Thessaly
Heroin Dependence, Opioid-Related Disorders
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
The purpose of this study is to compare the clinical efficacy of the buprenorphine/naloxone combination tablet to methadone for opioid maintenance treatment.
- Trial name
- NCT00000328
- Testing
- Opioid-Related Disorders
- Where
- United States
- Sponsor
- University of Colorado, Denver
Heroin Dependence
Effects of Buspirone in Opiate Withdrawal
Dependence on heroin is a major public health problem because of its association with criminality, law enforcement costs and healthcare costs.
- Trial name
- NCT00326235
- Testing
- Buspirone
- Where
- United States
- Sponsor
- National Institute on Drug Abuse (NIDA)
Cancer
Diamorphine or Alfentanil for Subcutaneous Use in Hospice In-patients?
OBJECTIVES: How does Alfentanil compare with the standard drug Diamorphine for subcutaneous analgesia in the palliative care setting? STUDY DESIGN: An open-label pilot comparison between alfentanil and diamorphine for palliative…
- Trial name
- DASH (NCT01049672)
- Testing
- Alfentanil, Diamorphine
- Where
- United Kingdom
- Volunteers
- 18 people
- Sponsor
- Gloucestershire Hospitals NHS Foundation Trust
Heroin Addiction
Methadone Maintenance for Prisoners
This five-year study examines the benefits of methadone maintenance treatment initiated in prison and continued in the community to male offenders who were previously, but not currently, heroin-dependent.
- Trial name
- MMP (NCT00378079)
- Testing
- Counseling Only, Counseling + Transfer, Counseling + Methadone
- Where
- United States
- Volunteers
- 211 people, healthy volunteers welcome
- Sponsor
- Friends Research Institute, Inc.
Opioid Dependence
The Separate and Combined Effects of Vivitrol and Opiate Abstinence Reinforcement in the Treatment of Opioid Dependence
In this 5-year study, the investigators propose to evaluate the separate and combined effects of the FDA-approved formulation of extended release naltrexone (Vivitrol®) and employment-based reinforcement of opiate abstinence in…
- Trial name
- NCT01556425
- Testing
- Vivitrol, Employment-based opiate abstinence reinforcement, Usual Care Control
- Where
- United States
- Volunteers
- 84 people
- Sponsor
- Johns Hopkins University
Heroin Dependence
Laser Meridian Massage in Heroin Addicts
A case-controlled study is conducted to investigate the effect of adjuvant laser meridian massage in heroin addicts with methadone treatment and establish the model of laser meridian massage treatment for drug addiction.
- Trial name
- NCT04003077
- Testing
- laser meridian massage
- Where
- Taiwan
- Volunteers
- 30 people
- Sponsor
- Chang Gung Memorial Hospital
Heroin Dependence
Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
The purpose of this study is to compare liquid and tablet buprenorphine formulations.
- Trial name
- NCT00000302
- Testing
- Buprenorphine
- Where
- United States
- Sponsor
- National Institute on Drug Abuse (NIDA)
Opiate Dependence
Entry Into Comprehensive Methadone Treatment Via Interim Maintenance
The purpose of the study is to determine whether one of three levels of counseling intensity will be associated with better treatment outcomes when combined with methadone maintenance treatment for heroin-addicted adults drawn…
- Trial name
- NCT00712036
- Testing
- Interim, Comprehensive, Restored
- Where
- United States
- Volunteers
- 230 people
- Sponsor
- Friends Research Institute, Inc.
Substance-Related Disorders
Brain Electrophysiological Study(EEG/ERP) on Opiate Addicts Treating by Bilateral NAc/ALIC Deep Brain Stimulation
Drug addiction is compulsive and spontaneous drug-taking behavior which is characterized by non-medical usage, long and repeated exposure to addictive drugs and gradually increasing drug-taking dosage and frequency,and become a…
- Trial name
- NCT02594306
- Testing
- Emotional pictures stimulation system, Deep brain stimulation, adjacent contact stimulation
- Where
- China
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Tang-Du Hospital
Heroin Dependence, Substance-Related Disorders
Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1
The purpose of this study is the use of buprenorphine/naloxone in treatment of opioid dependence.
- Trial name
- NCT00015171
- Testing
- Buprenorphine/naloxone
- Where
- United States
- Sponsor
- National Institute on Drug Abuse (NIDA)
Heroin Dependence
Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals
A short-term treatment with buprenorphine prior to initiating treatment with naltrexone may increase the proportion of heroin-dependent patients successfully inducted onto Vivitrol.
- Trial name
- NCT03711318
- Testing
- Buprenorphine/naloxone
- Where
- United States
- Volunteers
- 8 people, healthy volunteers welcome
- Sponsor
- New York State Psychiatric Institute
Heroin Dependence, Opioid-Related Disorders
Buprenorphine and Naloxone Combination Study - 10
The purpose of this study is to examine pharmacokinetics and dose proportionality of sublingual tablets containing varying doses of buprenorphine and naloxone.
- Trial name
- NCT00015288
- Testing
- Buprenorphine/naloxone
- Where
- United States
- Sponsor
- National Institute on Drug Abuse (NIDA)
Opiate Use Disorder
Mindfulness-Oriented Recovery Enhancement (MORE) in Heroin Addiction
In this study, neuroimaging of reward processing, drug cue reactivity and inhibitory control is used before and immediately after 8 weeks of two types of group therapy in individuals with opioid addiction; clinical outcomes will…
- Trial name
- MORE (NCT04112186)
- Testing
- Behavioral group therapy #1, Behavioral group therapy #2
- Where
- United States
- Volunteers
- 157 people, healthy volunteers welcome
- Sponsor
- Icahn School of Medicine at Mount Sinai
Respiratory Depression
Observation of Respiration Following Regional Anaesthesia With Intrathecal Opioids for Caesarean Section
Spinal Administration of opioids offers segmental analgesia, but has side effects including pruritus, nausea and vomiting, urinary retention, hypotension, and respiratory depression, both early and delayed.
- Trial name
- NCT00544947
- Where
- United Kingdom
- Volunteers
- 90 people, healthy volunteers welcome
- Sponsor
- NHS Greater Clyde and Glasgow
Heroin Dependence, Opioid-Related Disorders
Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry
The purpose of this study is to compare the effectiveness of extended-release naltrexone (XR-NTX) vs. enhanced treatment-as-usual (TAU) among opioid dependent adults leaving NYC jails.
- Trial name
- XOR (NCT01999946)
- Testing
- Extended-Release Naltrexone
- Where
- 2 sites in United States
- Volunteers
- 217 people
- Sponsor
- NYU Langone Health